Etiology of and risk factors for transient and persistent aminotransferase elevation in a population of virus-free blood donors: a multicentre study

Dig Liver Dis. 2010 Jun;42(6):441-5. doi: 10.1016/j.dld.2009.06.017. Epub 2009 Jul 29.

Abstract

Aim: We evaluated the etiology and risk factors for transient and persistently elevated aspartate and/or alanine aminotransferase levels in virus-free blood donors.

Inclusion criteria: HBsAg/HBV-DNA and anti-HCV/HCV-RNA negative blood donors with elevated aspartate aminotransferase and/or alanine aminotransferase, observed in 5 blood transfusion centres in Italy from 2004 to 2005. Aspartate aminotransferase/alanine aminotransferase levels were measured at entry and every 2 months during a period of 6 months.

Results: 291 individuals were evaluated (144 with persistent and 147 with transient abnormal aminotransferases). High body mass index was the most frequent (75.5%) etiological factor and was more common in the persistent elevated levels group, compared to the transient elevated levels group (82.0% vs 65.3%; p<0.01). Excessive alcohol intake (>2 units/day) was reported in 23.6%, with no differences between the two groups. Instead, recent use of medication or paint exposure were most frequently associated with transient elevated levels than persistent elevated levels (61.6% vs 23.3% for drugs and 13.7% vs 4.3% for paint, p<0.001). Considering the participants with transient elevated levels as controls, the multivariate analysis showed that high body mass index was the only independent predictor of persistent elevated aminotransferase levels (OR=5.3; 95%CI=1.88-13.42 for those with body mass index>29.9).

Conclusions: In virus-free blood donors, excessive body mass index is the most frequent etiological factor of abnormal aminotransferases and it is the sole risk factor associated with persistently elevated aminotransferases.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Adult
  • Alanine Transaminase / blood*
  • Aspartate Aminotransferases / blood*
  • Blood Donors*
  • Blood Transfusion / methods*
  • Body Mass Index
  • Disease Transmission, Infectious / prevention & control*
  • Female
  • Follow-Up Studies
  • Hepacivirus / genetics
  • Hepacivirus / immunology
  • Hepatitis B Surface Antigens / analysis
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology
  • Hepatitis B, Chronic / enzymology*
  • Hepatitis B, Chronic / transmission
  • Hepatitis B, Chronic / virology
  • Hepatitis C Antibodies / analysis
  • Hepatitis C, Chronic / enzymology*
  • Hepatitis C, Chronic / transmission
  • Hepatitis C, Chronic / virology
  • Humans
  • Male
  • RNA, Viral / analysis
  • Retrospective Studies
  • Risk Factors

Substances

  • Hepatitis B Surface Antigens
  • Hepatitis C Antibodies
  • RNA, Viral
  • Aspartate Aminotransferases
  • Alanine Transaminase